Therapy for idiopathic pulmonary fibrosis: lessons from pooled data analyses

Affiliations

¹ Dept of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, Australia Sydney Medical School, University of Sydney, Sydney, Australia.
² Dept of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, Australia Sydney Medical School, University of Sydney, Sydney, Australia tameracorte@mac.com.

Free article

Editorial

Lauren K Troy et al. Eur Respir J. 2016 Jan.

Free article

. 2016 Jan;47(1):27-30.

doi: 10.1183/13993003.01669-2015.

¹ Dept of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, Australia Sydney Medical School, University of Sydney, Sydney, Australia.
² Dept of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, Australia Sydney Medical School, University of Sydney, Sydney, Australia tameracorte@mac.com.

No abstract available

Comment on

Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials.
Noble PW, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, Lancaster L, Lederer DJ, Leff JA, Nathan SD, Pereira CA, Swigris JJ, Valeyre D, King TE Jr. Noble PW, et al. Eur Respir J. 2016 Jan;47(1):243-53. doi: 10.1183/13993003.00026-2015. Epub 2015 Dec 2. Eur Respir J. 2016. PMID: 26647432 Free PMC article.